Maven Securities’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$478K Buy
+100,000
New +$482K 0.01% 394

Other funds holding ABUS

Maven Securities's ABUS Position: Q3 2026 in Review

Maven Securities opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 100,000 shares worth $478K. The stake represents 0.01% of the portfolio and ranks #393 among its holdings. This is a return to the name: Maven Securities previously reported a position in ABUS as recently as Q1 2021.

Maven Securities first reported a position in ABUS in Q1 2021 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Maven Securities held 100,000 shares of Arbutus Biopharma worth $478K as of Q3 2026.
  • Arbutus Biopharma was a new Maven Securities position in Q3 2026.
  • Arbutus Biopharma made up 0.01% of Maven Securities's portfolio in Q3 2026, its #393 holding.
  • Maven Securities first reported a position in Arbutus Biopharma in Q1 2021 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Maven Securities's 13F filing for Q3 2026, filed 13 Nov 2026.